Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**2,4-Dinitrophenol** is an organic compound (C6H4N2O5) and member of the dinitrophenol family, formerly used industrially in wood preservatives, herbicides, dyes, sulfur dye manufacture, and explosives (including as a TNT precursor). Clinically, it was prescribed as one of the earliest weight-loss drugs in the 1930s due to its ability to raise basal metabolic rate through mitochondrial uncoupling, but was banned for human use due to risk of fatal hyperthermia, multi-organ toxicity, and deaths. As a protonophore, 2,4-dinitrophenol disrupts ATP synthesis in mitochondria by collapsing the proton gradient, leading to energy dissipation as heat. It is not approved for pharmaceutical use, is classified as hazardous, and continues to be used illegally for weight loss purposes[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2,4-dinitrophenol.